Glutathione and thymosin alpha-1 for cold and flu season: what the evidence says

What did @k9dresser actually say?

The creator shared a personal protocol she is using after her son tested positive for both COVID-19 and influenza A. She said she takes "one milligram" of thymosin alpha-1 daily for 10 days and "200 milligrams three times a week" of glutathione, calling both peptides rated to "boost your immune system and ward off the chance of getting sick or shorten the time of being sick." She was not advising her son to use them, just herself. She also shared that she lost her mother to COVID in 2022, which gives her reasoning some real emotional weight even if the clinical picture is more complicated.

To be clear about what she did not say: she did not claim these are cures, she did not diagnose anything, and she did include a disclaimer. That context matters when evaluating the video.

Does the science back this up?

Partially, but the evidence is thinner than a short TikTok makes it sound. Thymosin alpha-1 has the stronger case. Glutathione's oral and even injectable bioavailability story is messier, and neither compound has been approved by the FDA for immune support in healthy adults.

Thymosin alpha-1 (Ta1) is a naturally occurring peptide from the thymus gland that has been studied seriously. A 2020 meta-analysis by Liu et al. in the Journal of Infection looked at Ta1 use in severe COVID-19 patients and found associations with reduced mortality and faster lymphocyte recovery. A 2021 study by Shi et al. in Clinical Infectious Diseases found Ta1 reduced 28-day mortality in critically ill COVID-19 patients. Important caveat: these were sick, hospitalized patients, not healthy adults trying to prevent infection. Extrapolating from ICU data to outpatient prevention is a real leap.

Glutathione is more complicated. It is a powerful endogenous antioxidant. A 2021 paper by Polonikov in ACS Infectious Diseases proposed that glutathione deficiency may worsen COVID-19 severity, which is interesting but not the same as showing supplementation prevents infection. Oral glutathione has poor bioavailability. Liposomal and inhaled forms show better absorption in some trials, but the evidence base is still early-stage.

What did they get wrong, or right?

The framing that these are "rates to boost your immune system" is where the video oversimplifies. Immune modulation is not the same as immune boosting, and Ta1 in particular works by normalizing dysregulated immune responses, not by simply cranking up defenses. Using the word "boost" flattens a nuanced mechanism into something that sounds like a vitamin ad.

The 10-day dosing structure for Ta1 is consistent with protocols studied in clinical research, which is worth acknowledging. She is not making the protocol up from nothing.

However, the claim that these peptides will "ward off the chance of getting sick" in a healthy adult who has been exposed is not supported by controlled trial data. There are no randomized controlled trials showing Ta1 prevents COVID-19 infection in healthy, unvaccinated or vaccinated adults post-exposure. The creator deserves credit for not pushing her son to use them and for being honest about her personal loss. That humanity does not change the evidentiary gap, but it is not nothing.

What should you actually know?

If you are considering thymosin alpha-1 or glutathione for immune support, here is the honest version of where the science stands. Ta1 has the most legitimate research behind it of any peptide in this category, but most of that research involves immunocompromised patients or critically ill individuals, not healthy adults doing prevention. The prevention use case is real in functional and integrative medicine circles, but it is not backed by large randomized trials in healthy populations.

Glutathione supplementation for COVID prevention is even more speculative. The deficiency-severity connection is plausible and worth more research, but "low glutathione is associated with worse outcomes" is not the same as "taking extra glutathione prevents infection."

Both compounds require a prescription or clinical oversight in most legitimate telehealth contexts, and neither is FDA-approved for this indication. Compounded versions vary significantly in quality and purity. Anyone pursuing these compounds should work with a licensed provider who can assess their individual health status, not replicate a social media protocol.